These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 23280376)

  • 1. How quickly do physicians adopt new drugs? The case of second-generation antipsychotics.
    Huskamp HA; O'Malley AJ; Horvitz-Lennon M; Taub AL; Berndt ER; Donohue JM
    Psychiatr Serv; 2013 Apr; 64(4):324-30. PubMed ID: 23280376
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regional Variation in Physician Adoption of Antipsychotics: Impact on US Medicare Expenditures.
    Donohue JM; Normand SL; Horvitz-Lennon M; Men A; Berndt ER; Huskamp HA
    J Ment Health Policy Econ; 2016 Jun; 19(2):69-78. PubMed ID: 27453458
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in physician antipsychotic prescribing preferences, 2002-2007.
    Donohue J; O'Malley AJ; Horvitz-Lennon M; Taub AL; Berndt ER; Huskamp HA
    Psychiatr Serv; 2014 Mar; 65(3):315-22. PubMed ID: 24337224
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patterns of Antipsychotic Prescribing by Physicians to Young Children.
    Huskamp HA; Horvitz-Lennon M; Berndt ER; Normand ST; Donohue JM
    Psychiatr Serv; 2016 Dec; 67(12):1307-1314. PubMed ID: 27417891
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Patient, Physician and Organizational Influences on Variation in Antipsychotic Prescribing Behavior.
    Tang Y; Chang CC; Lave JR; Gellad WF; Huskamp HA; Donohue JM
    J Ment Health Policy Econ; 2016 Mar; 19(1):45-59. PubMed ID: 27084793
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Antipsychotic prescription assessment in general practice: metabolic effects].
    Gignoux-Froment F; de Montleau F; Saravane D; Verret C
    Encephale; 2012 Dec; 38(6):453-9. PubMed ID: 23200610
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Average duration of treatment with antipsychotics among concession card holders in Australia.
    Kjosavik SR; Gillam MH; Roughead EE
    Aust N Z J Psychiatry; 2017 Jul; 51(7):719-726. PubMed ID: 28195003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evolution of general practitioners' preferences for antipsychotics in France, 2003-2010.
    Gallini A; Gardette V; Oumouhou N; Andrieu S; Donohue JM
    Psychiatr Serv; 2015 Apr; 66(4):434-7. PubMed ID: 25588416
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Antipsychotic prescribing: do conflict of interest policies make a difference?
    Anderson TS; Huskamp HA; Epstein AJ; Barry CL; Men A; Berndt ER; Horvitz-Lennon M; Normand SL; Donohue JM
    Med Care; 2015 Apr; 53(4):338-45. PubMed ID: 25769055
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Second-Generation Antipsychotic Prescribing Patterns for Pediatric Patients Enrolled in West Virginia Medicaid.
    Melvin KE; Hart JC; Sorvig RD
    Psychiatr Serv; 2017 Oct; 68(10):1061-1067. PubMed ID: 28566023
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The heterogeneity of concentrated prescribing behavior: Theory and evidence from antipsychotics.
    Berndt ER; Gibbons RS; Kolotilin A; Taub AL
    J Health Econ; 2015 Mar; 40():26-39. PubMed ID: 25575344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. National Patterns of Commonly Prescribed Psychotropic Medications to Young People.
    Sultan RS; Correll CU; Schoenbaum M; King M; Walkup JT; Olfson M
    J Child Adolesc Psychopharmacol; 2018 Apr; 28(3):158-165. PubMed ID: 29376743
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Factors Influencing the Use of Second-Generation Antipsychotics in Children with Psychosis.
    Ramachandran S; Banahan BF; Bentley JP; West-Strum DS; Patel AS
    J Manag Care Spec Pharm; 2016 Aug; 22(8):948-57. PubMed ID: 27459658
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evolution of First-generation and Second-generation Antipsychotic Prescribing Patterns in Belgium Between 1997 and 2012: A Population-based Study.
    Morrens M; Destoop M; Cleymans S; VAN DER Spek S; Dom G
    J Psychiatr Pract; 2015 Jul; 21(4):248-58. PubMed ID: 26164050
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A population-based study of antipsychotic prescription trends in children and adolescents in British Columbia, from 1996 to 2011.
    Ronsley R; Scott D; Warburton WP; Hamdi RD; Louie DC; Davidson J; Panagiotopoulos C
    Can J Psychiatry; 2013 Jun; 58(6):361-9. PubMed ID: 23768264
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Variation in long-term antipsychotic polypharmacy and high-dose prescribing across physicians and hospitals.
    Latimer EA; Naidu A; Moodie EE; Clark RE; Malla AK; Tamblyn R; Wynant W
    Psychiatr Serv; 2014 Oct; 65(10):1210-7. PubMed ID: 24981557
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Factors affecting general practitioners' decisions to adopt new prescription drugs - cohort analyses using Australian longitudinal physician survey data.
    Zhang Y; Méndez SJ; Scott A
    BMC Health Serv Res; 2019 Feb; 19(1):94. PubMed ID: 30728010
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antipsychotic Medication Prescribing Trends in a Pediatric Population in Northern Poland 2008-2012.
    Waszak PM; Zagożdżon P; Pierucka M; Kubanek A
    J Child Adolesc Psychopharmacol; 2018 Nov; 28(9):631-636. PubMed ID: 30048153
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diffusion of antipsychotics in the US And French markets, 1998-2008.
    Gallini A; Donohue JM; Huskamp HA
    Psychiatr Serv; 2013 Jul; 64(7):680-7. PubMed ID: 23584568
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical decision making in antipsychotic drug choice for schizophrenia.
    Hamann J; Langer B; Leucht S; Busch R; Kissling W
    Am J Psychiatry; 2004 Jul; 161(7):1301-4. PubMed ID: 15229068
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.